nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP3A4—Estropipate—osteoporosis	0.0853	0.158	CbGbCtD
Oxymorphone—CYP3A4—Calcitriol—osteoporosis	0.0853	0.158	CbGbCtD
Oxymorphone—CYP2D6—Cholecalciferol—osteoporosis	0.0691	0.128	CbGbCtD
Oxymorphone—CYP3A4—Ergocalciferol—osteoporosis	0.0682	0.126	CbGbCtD
Oxymorphone—CYP3A4—Raloxifene—osteoporosis	0.0569	0.105	CbGbCtD
Oxymorphone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.055	0.102	CbGbCtD
Oxymorphone—CYP3A4—Cholecalciferol—osteoporosis	0.044	0.0814	CbGbCtD
Oxymorphone—CYP3A4—Conjugated Estrogens—osteoporosis	0.0404	0.0748	CbGbCtD
Oxymorphone—CYP3A4—Estradiol—osteoporosis	0.0354	0.0656	CbGbCtD
Oxymorphone—Body temperature increased—Ibandronate—osteoporosis	0.000699	0.00153	CcSEcCtD
Oxymorphone—Confusional state—Pamidronate—osteoporosis	0.000698	0.00153	CcSEcCtD
Oxymorphone—Vertigo—Zoledronate—osteoporosis	0.000696	0.00153	CcSEcCtD
Oxymorphone—Syncope—Zoledronate—osteoporosis	0.000695	0.00152	CcSEcCtD
Oxymorphone—Oedema—Pamidronate—osteoporosis	0.000692	0.00152	CcSEcCtD
Oxymorphone—Urticaria—Calcitriol—osteoporosis	0.000687	0.00151	CcSEcCtD
Oxymorphone—Palpitations—Zoledronate—osteoporosis	0.000685	0.0015	CcSEcCtD
Oxymorphone—Body temperature increased—Calcitriol—osteoporosis	0.000684	0.0015	CcSEcCtD
Oxymorphone—Abdominal pain—Calcitriol—osteoporosis	0.000684	0.0015	CcSEcCtD
Oxymorphone—Shock—Pamidronate—osteoporosis	0.000681	0.00149	CcSEcCtD
Oxymorphone—Loss of consciousness—Zoledronate—osteoporosis	0.000681	0.00149	CcSEcCtD
Oxymorphone—Hypersensitivity—Estropipate—osteoporosis	0.000679	0.00149	CcSEcCtD
Oxymorphone—Nervous system disorder—Pamidronate—osteoporosis	0.000679	0.00149	CcSEcCtD
Oxymorphone—Urinary tract disorder—Estradiol—osteoporosis	0.000677	0.00148	CcSEcCtD
Oxymorphone—Vomiting—Etidronic acid—osteoporosis	0.000677	0.00148	CcSEcCtD
Oxymorphone—Tachycardia—Pamidronate—osteoporosis	0.000676	0.00148	CcSEcCtD
Oxymorphone—Urethral disorder—Estradiol—osteoporosis	0.000672	0.00147	CcSEcCtD
Oxymorphone—Convulsion—Zoledronate—osteoporosis	0.000671	0.00147	CcSEcCtD
Oxymorphone—Dermatitis—Etidronic acid—osteoporosis	0.000671	0.00147	CcSEcCtD
Oxymorphone—Vertigo—Conjugated Estrogens—osteoporosis	0.00067	0.00147	CcSEcCtD
Oxymorphone—Hyperhidrosis—Pamidronate—osteoporosis	0.000669	0.00147	CcSEcCtD
Oxymorphone—Syncope—Conjugated Estrogens—osteoporosis	0.000669	0.00147	CcSEcCtD
Oxymorphone—Hypertension—Zoledronate—osteoporosis	0.000669	0.00147	CcSEcCtD
Oxymorphone—Hypersensitivity—Alendronate—osteoporosis	0.000669	0.00147	CcSEcCtD
Oxymorphone—Headache—Etidronic acid—osteoporosis	0.000667	0.00146	CcSEcCtD
Oxymorphone—Asthenia—Estropipate—osteoporosis	0.000661	0.00145	CcSEcCtD
Oxymorphone—Visual impairment—Estradiol—osteoporosis	0.000661	0.00145	CcSEcCtD
Oxymorphone—Anorexia—Pamidronate—osteoporosis	0.00066	0.00145	CcSEcCtD
Oxymorphone—Chest pain—Zoledronate—osteoporosis	0.00066	0.00145	CcSEcCtD
Oxymorphone—Palpitations—Conjugated Estrogens—osteoporosis	0.000659	0.00144	CcSEcCtD
Oxymorphone—Insomnia—Risedronate—osteoporosis	0.000659	0.00144	CcSEcCtD
Oxymorphone—Anxiety—Zoledronate—osteoporosis	0.000657	0.00144	CcSEcCtD
Oxymorphone—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000656	0.00144	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000655	0.00144	CcSEcCtD
Oxymorphone—Pruritus—Estropipate—osteoporosis	0.000652	0.00143	CcSEcCtD
Oxymorphone—Asthenia—Alendronate—osteoporosis	0.000651	0.00143	CcSEcCtD
Oxymorphone—Hypersensitivity—Ibandronate—osteoporosis	0.000651	0.00143	CcSEcCtD
Oxymorphone—Dyspnoea—Risedronate—osteoporosis	0.000649	0.00142	CcSEcCtD
Oxymorphone—Hypotension—Pamidronate—osteoporosis	0.000647	0.00142	CcSEcCtD
Oxymorphone—Convulsion—Conjugated Estrogens—osteoporosis	0.000646	0.00142	CcSEcCtD
Oxymorphone—Dry mouth—Zoledronate—osteoporosis	0.000645	0.00141	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000645	0.00141	CcSEcCtD
Oxymorphone—Fatigue—Ethinyl Estradiol—osteoporosis	0.000644	0.00141	CcSEcCtD
Oxymorphone—Pruritus—Alendronate—osteoporosis	0.000642	0.00141	CcSEcCtD
Oxymorphone—Dyspepsia—Risedronate—osteoporosis	0.000641	0.0014	CcSEcCtD
Oxymorphone—Eye disorder—Estradiol—osteoporosis	0.000641	0.0014	CcSEcCtD
Oxymorphone—Constipation—Ethinyl Estradiol—osteoporosis	0.000639	0.0014	CcSEcCtD
Oxymorphone—Confusional state—Zoledronate—osteoporosis	0.000638	0.0014	CcSEcCtD
Oxymorphone—Hypersensitivity—Calcitriol—osteoporosis	0.000637	0.0014	CcSEcCtD
Oxymorphone—Cardiac disorder—Estradiol—osteoporosis	0.000637	0.00139	CcSEcCtD
Oxymorphone—Flushing—Estradiol—osteoporosis	0.000637	0.00139	CcSEcCtD
Oxymorphone—Chest pain—Conjugated Estrogens—osteoporosis	0.000635	0.00139	CcSEcCtD
Oxymorphone—Asthenia—Ibandronate—osteoporosis	0.000634	0.00139	CcSEcCtD
Oxymorphone—Anxiety—Conjugated Estrogens—osteoporosis	0.000633	0.00139	CcSEcCtD
Oxymorphone—Nausea—Etidronic acid—osteoporosis	0.000633	0.00139	CcSEcCtD
Oxymorphone—Oedema—Zoledronate—osteoporosis	0.000632	0.00139	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000631	0.00138	CcSEcCtD
Oxymorphone—Diarrhoea—Estropipate—osteoporosis	0.00063	0.00138	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Risedronate—osteoporosis	0.000629	0.00138	CcSEcCtD
Oxymorphone—Fatigue—Risedronate—osteoporosis	0.000628	0.00138	CcSEcCtD
Oxymorphone—Insomnia—Pamidronate—osteoporosis	0.000626	0.00137	CcSEcCtD
Oxymorphone—Pruritus—Ibandronate—osteoporosis	0.000625	0.00137	CcSEcCtD
Oxymorphone—Pain—Risedronate—osteoporosis	0.000623	0.00136	CcSEcCtD
Oxymorphone—Constipation—Risedronate—osteoporosis	0.000623	0.00136	CcSEcCtD
Oxymorphone—Angiopathy—Estradiol—osteoporosis	0.000622	0.00136	CcSEcCtD
Oxymorphone—Shock—Zoledronate—osteoporosis	0.000622	0.00136	CcSEcCtD
Oxymorphone—Diarrhoea—Alendronate—osteoporosis	0.000621	0.00136	CcSEcCtD
Oxymorphone—Asthenia—Calcitriol—osteoporosis	0.000621	0.00136	CcSEcCtD
Oxymorphone—Nervous system disorder—Zoledronate—osteoporosis	0.00062	0.00136	CcSEcCtD
Oxymorphone—Immune system disorder—Estradiol—osteoporosis	0.00062	0.00136	CcSEcCtD
Oxymorphone—Mediastinal disorder—Estradiol—osteoporosis	0.000618	0.00135	CcSEcCtD
Oxymorphone—Dyspnoea—Pamidronate—osteoporosis	0.000617	0.00135	CcSEcCtD
Oxymorphone—Tachycardia—Zoledronate—osteoporosis	0.000617	0.00135	CcSEcCtD
Oxymorphone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000616	0.00135	CcSEcCtD
Oxymorphone—Somnolence—Pamidronate—osteoporosis	0.000615	0.00135	CcSEcCtD
Oxymorphone—Skin disorder—Zoledronate—osteoporosis	0.000614	0.00135	CcSEcCtD
Oxymorphone—Pruritus—Calcitriol—osteoporosis	0.000612	0.00134	CcSEcCtD
Oxymorphone—Hyperhidrosis—Zoledronate—osteoporosis	0.000611	0.00134	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000611	0.00134	CcSEcCtD
Oxymorphone—Diarrhoea—Raloxifene—osteoporosis	0.000611	0.00134	CcSEcCtD
Oxymorphone—Dyspepsia—Pamidronate—osteoporosis	0.000609	0.00134	CcSEcCtD
Oxymorphone—Dizziness—Estropipate—osteoporosis	0.000609	0.00134	CcSEcCtD
Oxymorphone—Oedema—Conjugated Estrogens—osteoporosis	0.000609	0.00133	CcSEcCtD
Oxymorphone—Diarrhoea—Ibandronate—osteoporosis	0.000605	0.00132	CcSEcCtD
Oxymorphone—Anorexia—Zoledronate—osteoporosis	0.000603	0.00132	CcSEcCtD
Oxymorphone—Decreased appetite—Pamidronate—osteoporosis	0.000602	0.00132	CcSEcCtD
Oxymorphone—Mental disorder—Estradiol—osteoporosis	0.000601	0.00132	CcSEcCtD
Oxymorphone—Dizziness—Alendronate—osteoporosis	0.0006	0.00132	CcSEcCtD
Oxymorphone—Shock—Conjugated Estrogens—osteoporosis	0.000599	0.00131	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000598	0.00131	CcSEcCtD
Oxymorphone—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000597	0.00131	CcSEcCtD
Oxymorphone—Malnutrition—Estradiol—osteoporosis	0.000597	0.00131	CcSEcCtD
Oxymorphone—Fatigue—Pamidronate—osteoporosis	0.000597	0.00131	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Risedronate—osteoporosis	0.000596	0.0013	CcSEcCtD
Oxymorphone—Tachycardia—Conjugated Estrogens—osteoporosis	0.000594	0.0013	CcSEcCtD
Oxymorphone—Urticaria—Ethinyl Estradiol—osteoporosis	0.000593	0.0013	CcSEcCtD
Oxymorphone—Constipation—Pamidronate—osteoporosis	0.000592	0.0013	CcSEcCtD
Oxymorphone—Pain—Pamidronate—osteoporosis	0.000592	0.0013	CcSEcCtD
Oxymorphone—Diarrhoea—Calcitriol—osteoporosis	0.000592	0.0013	CcSEcCtD
Oxymorphone—Skin disorder—Conjugated Estrogens—osteoporosis	0.000591	0.0013	CcSEcCtD
Oxymorphone—Hypotension—Zoledronate—osteoporosis	0.000591	0.00129	CcSEcCtD
Oxymorphone—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00059	0.00129	CcSEcCtD
Oxymorphone—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00059	0.00129	CcSEcCtD
Oxymorphone—Dizziness—Raloxifene—osteoporosis	0.00059	0.00129	CcSEcCtD
Oxymorphone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000589	0.00129	CcSEcCtD
Oxymorphone—Flatulence—Estradiol—osteoporosis	0.000588	0.00129	CcSEcCtD
Oxymorphone—Tension—Estradiol—osteoporosis	0.000586	0.00128	CcSEcCtD
Oxymorphone—Vomiting—Estropipate—osteoporosis	0.000586	0.00128	CcSEcCtD
Oxymorphone—Dizziness—Ibandronate—osteoporosis	0.000584	0.00128	CcSEcCtD
Oxymorphone—Dermatitis—Estropipate—osteoporosis	0.00058	0.00127	CcSEcCtD
Oxymorphone—Anorexia—Conjugated Estrogens—osteoporosis	0.00058	0.00127	CcSEcCtD
Oxymorphone—Nervousness—Estradiol—osteoporosis	0.00058	0.00127	CcSEcCtD
Oxymorphone—Urticaria—Risedronate—osteoporosis	0.000579	0.00127	CcSEcCtD
Oxymorphone—Headache—Estropipate—osteoporosis	0.000577	0.00126	CcSEcCtD
Oxymorphone—Vomiting—Alendronate—osteoporosis	0.000577	0.00126	CcSEcCtD
Oxymorphone—Body temperature increased—Risedronate—osteoporosis	0.000576	0.00126	CcSEcCtD
Oxymorphone—Abdominal pain—Risedronate—osteoporosis	0.000576	0.00126	CcSEcCtD
Oxymorphone—Insomnia—Zoledronate—osteoporosis	0.000572	0.00125	CcSEcCtD
Oxymorphone—Dermatitis—Alendronate—osteoporosis	0.000572	0.00125	CcSEcCtD
Oxymorphone—Feeling abnormal—Pamidronate—osteoporosis	0.00057	0.00125	CcSEcCtD
Oxymorphone—Hypotension—Conjugated Estrogens—osteoporosis	0.000569	0.00125	CcSEcCtD
Oxymorphone—Headache—Alendronate—osteoporosis	0.000569	0.00125	CcSEcCtD
Oxymorphone—Vomiting—Raloxifene—osteoporosis	0.000568	0.00124	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Pamidronate—osteoporosis	0.000566	0.00124	CcSEcCtD
Oxymorphone—Dyspnoea—Zoledronate—osteoporosis	0.000564	0.00124	CcSEcCtD
Oxymorphone—Dermatitis—Raloxifene—osteoporosis	0.000562	0.00123	CcSEcCtD
Oxymorphone—Somnolence—Zoledronate—osteoporosis	0.000562	0.00123	CcSEcCtD
Oxymorphone—Vomiting—Ibandronate—osteoporosis	0.000562	0.00123	CcSEcCtD
Oxymorphone—Headache—Raloxifene—osteoporosis	0.000559	0.00123	CcSEcCtD
Oxymorphone—Dermatitis—Ibandronate—osteoporosis	0.000557	0.00122	CcSEcCtD
Oxymorphone—Dyspepsia—Zoledronate—osteoporosis	0.000557	0.00122	CcSEcCtD
Oxymorphone—Headache—Ibandronate—osteoporosis	0.000554	0.00121	CcSEcCtD
Oxymorphone—Insomnia—Conjugated Estrogens—osteoporosis	0.000551	0.00121	CcSEcCtD
Oxymorphone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00055	0.00121	CcSEcCtD
Oxymorphone—Vomiting—Calcitriol—osteoporosis	0.00055	0.00121	CcSEcCtD
Oxymorphone—Decreased appetite—Zoledronate—osteoporosis	0.00055	0.0012	CcSEcCtD
Oxymorphone—Agitation—Estradiol—osteoporosis	0.000549	0.0012	CcSEcCtD
Oxymorphone—Nausea—Estropipate—osteoporosis	0.000547	0.0012	CcSEcCtD
Oxymorphone—Abdominal pain—Pamidronate—osteoporosis	0.000547	0.0012	CcSEcCtD
Oxymorphone—Body temperature increased—Pamidronate—osteoporosis	0.000547	0.0012	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000546	0.0012	CcSEcCtD
Oxymorphone—Fatigue—Zoledronate—osteoporosis	0.000545	0.00119	CcSEcCtD
Oxymorphone—Dermatitis—Calcitriol—osteoporosis	0.000545	0.00119	CcSEcCtD
Oxymorphone—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000543	0.00119	CcSEcCtD
Oxymorphone—Headache—Calcitriol—osteoporosis	0.000542	0.00119	CcSEcCtD
Oxymorphone—Somnolence—Conjugated Estrogens—osteoporosis	0.000541	0.00119	CcSEcCtD
Oxymorphone—Constipation—Zoledronate—osteoporosis	0.000541	0.00118	CcSEcCtD
Oxymorphone—Pain—Zoledronate—osteoporosis	0.000541	0.00118	CcSEcCtD
Oxymorphone—Nausea—Alendronate—osteoporosis	0.000539	0.00118	CcSEcCtD
Oxymorphone—Hypersensitivity—Risedronate—osteoporosis	0.000537	0.00118	CcSEcCtD
Oxymorphone—Vertigo—Estradiol—osteoporosis	0.000536	0.00118	CcSEcCtD
Oxymorphone—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000536	0.00117	CcSEcCtD
Oxymorphone—Asthenia—Ethinyl Estradiol—osteoporosis	0.000536	0.00117	CcSEcCtD
Oxymorphone—Syncope—Estradiol—osteoporosis	0.000535	0.00117	CcSEcCtD
Oxymorphone—Nausea—Raloxifene—osteoporosis	0.00053	0.00116	CcSEcCtD
Oxymorphone—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000529	0.00116	CcSEcCtD
Oxymorphone—Pruritus—Ethinyl Estradiol—osteoporosis	0.000528	0.00116	CcSEcCtD
Oxymorphone—Palpitations—Estradiol—osteoporosis	0.000528	0.00116	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000526	0.00115	CcSEcCtD
Oxymorphone—Fatigue—Conjugated Estrogens—osteoporosis	0.000525	0.00115	CcSEcCtD
Oxymorphone—Nausea—Ibandronate—osteoporosis	0.000525	0.00115	CcSEcCtD
Oxymorphone—Loss of consciousness—Estradiol—osteoporosis	0.000525	0.00115	CcSEcCtD
Oxymorphone—Asthenia—Risedronate—osteoporosis	0.000523	0.00114	CcSEcCtD
Oxymorphone—Feeling abnormal—Zoledronate—osteoporosis	0.000521	0.00114	CcSEcCtD
Oxymorphone—Pain—Conjugated Estrogens—osteoporosis	0.000521	0.00114	CcSEcCtD
Oxymorphone—Constipation—Conjugated Estrogens—osteoporosis	0.000521	0.00114	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Zoledronate—osteoporosis	0.000517	0.00113	CcSEcCtD
Oxymorphone—Hypertension—Estradiol—osteoporosis	0.000516	0.00113	CcSEcCtD
Oxymorphone—Pruritus—Risedronate—osteoporosis	0.000515	0.00113	CcSEcCtD
Oxymorphone—Nausea—Calcitriol—osteoporosis	0.000514	0.00113	CcSEcCtD
Oxymorphone—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000511	0.00112	CcSEcCtD
Oxymorphone—Hypersensitivity—Pamidronate—osteoporosis	0.00051	0.00112	CcSEcCtD
Oxymorphone—Chest pain—Estradiol—osteoporosis	0.000508	0.00111	CcSEcCtD
Oxymorphone—Anxiety—Estradiol—osteoporosis	0.000507	0.00111	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000505	0.00111	CcSEcCtD
Oxymorphone—Urticaria—Zoledronate—osteoporosis	0.000502	0.0011	CcSEcCtD
Oxymorphone—Body temperature increased—Zoledronate—osteoporosis	0.0005	0.0011	CcSEcCtD
Oxymorphone—Abdominal pain—Zoledronate—osteoporosis	0.0005	0.0011	CcSEcCtD
Oxymorphone—Diarrhoea—Risedronate—osteoporosis	0.000498	0.00109	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000498	0.00109	CcSEcCtD
Oxymorphone—Dry mouth—Estradiol—osteoporosis	0.000497	0.00109	CcSEcCtD
Oxymorphone—Asthenia—Pamidronate—osteoporosis	0.000497	0.00109	CcSEcCtD
Oxymorphone—Dizziness—Ethinyl Estradiol—osteoporosis	0.000494	0.00108	CcSEcCtD
Oxymorphone—Confusional state—Estradiol—osteoporosis	0.000491	0.00108	CcSEcCtD
Oxymorphone—Pruritus—Pamidronate—osteoporosis	0.00049	0.00107	CcSEcCtD
Oxymorphone—Oedema—Estradiol—osteoporosis	0.000487	0.00107	CcSEcCtD
Oxymorphone—Urticaria—Conjugated Estrogens—osteoporosis	0.000484	0.00106	CcSEcCtD
Oxymorphone—Dizziness—Risedronate—osteoporosis	0.000482	0.00106	CcSEcCtD
Oxymorphone—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000481	0.00105	CcSEcCtD
Oxymorphone—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000481	0.00105	CcSEcCtD
Oxymorphone—Shock—Estradiol—osteoporosis	0.000479	0.00105	CcSEcCtD
Oxymorphone—Nervous system disorder—Estradiol—osteoporosis	0.000478	0.00105	CcSEcCtD
Oxymorphone—Tachycardia—Estradiol—osteoporosis	0.000476	0.00104	CcSEcCtD
Oxymorphone—Vomiting—Ethinyl Estradiol—osteoporosis	0.000475	0.00104	CcSEcCtD
Oxymorphone—Diarrhoea—Pamidronate—osteoporosis	0.000474	0.00104	CcSEcCtD
Oxymorphone—Skin disorder—Estradiol—osteoporosis	0.000473	0.00104	CcSEcCtD
Oxymorphone—Hyperhidrosis—Estradiol—osteoporosis	0.000471	0.00103	CcSEcCtD
Oxymorphone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000471	0.00103	CcSEcCtD
Oxymorphone—Headache—Ethinyl Estradiol—osteoporosis	0.000468	0.00103	CcSEcCtD
Oxymorphone—Hypersensitivity—Zoledronate—osteoporosis	0.000466	0.00102	CcSEcCtD
Oxymorphone—Vomiting—Risedronate—osteoporosis	0.000463	0.00101	CcSEcCtD
Oxymorphone—Dermatitis—Risedronate—osteoporosis	0.000459	0.00101	CcSEcCtD
Oxymorphone—Dizziness—Pamidronate—osteoporosis	0.000458	0.001	CcSEcCtD
Oxymorphone—Headache—Risedronate—osteoporosis	0.000456	0.001	CcSEcCtD
Oxymorphone—Asthenia—Zoledronate—osteoporosis	0.000454	0.000994	CcSEcCtD
Oxymorphone—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000449	0.000983	CcSEcCtD
Oxymorphone—Pruritus—Zoledronate—osteoporosis	0.000447	0.00098	CcSEcCtD
Oxymorphone—Nausea—Ethinyl Estradiol—osteoporosis	0.000444	0.000972	CcSEcCtD
Oxymorphone—Insomnia—Estradiol—osteoporosis	0.000441	0.000966	CcSEcCtD
Oxymorphone—Vomiting—Pamidronate—osteoporosis	0.00044	0.000965	CcSEcCtD
Oxymorphone—Asthenia—Conjugated Estrogens—osteoporosis	0.000437	0.000957	CcSEcCtD
Oxymorphone—Dermatitis—Pamidronate—osteoporosis	0.000436	0.000956	CcSEcCtD
Oxymorphone—Dyspnoea—Estradiol—osteoporosis	0.000434	0.000952	CcSEcCtD
Oxymorphone—Headache—Pamidronate—osteoporosis	0.000434	0.00095	CcSEcCtD
Oxymorphone—Somnolence—Estradiol—osteoporosis	0.000433	0.000949	CcSEcCtD
Oxymorphone—Diarrhoea—Zoledronate—osteoporosis	0.000433	0.000948	CcSEcCtD
Oxymorphone—Nausea—Risedronate—osteoporosis	0.000433	0.000948	CcSEcCtD
Oxymorphone—Pruritus—Conjugated Estrogens—osteoporosis	0.000431	0.000944	CcSEcCtD
Oxymorphone—Dyspepsia—Estradiol—osteoporosis	0.000429	0.00094	CcSEcCtD
Oxymorphone—Decreased appetite—Estradiol—osteoporosis	0.000424	0.000928	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Estradiol—osteoporosis	0.000421	0.000922	CcSEcCtD
Oxymorphone—Fatigue—Estradiol—osteoporosis	0.00042	0.000921	CcSEcCtD
Oxymorphone—Dizziness—Zoledronate—osteoporosis	0.000418	0.000916	CcSEcCtD
Oxymorphone—Pain—Estradiol—osteoporosis	0.000417	0.000913	CcSEcCtD
Oxymorphone—Constipation—Estradiol—osteoporosis	0.000417	0.000913	CcSEcCtD
Oxymorphone—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000417	0.000913	CcSEcCtD
Oxymorphone—Nausea—Pamidronate—osteoporosis	0.000411	0.000901	CcSEcCtD
Oxymorphone—Dizziness—Conjugated Estrogens—osteoporosis	0.000403	0.000882	CcSEcCtD
Oxymorphone—Vomiting—Zoledronate—osteoporosis	0.000402	0.000881	CcSEcCtD
Oxymorphone—Feeling abnormal—Estradiol—osteoporosis	0.000402	0.00088	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Estradiol—osteoporosis	0.000398	0.000873	CcSEcCtD
Oxymorphone—Dermatitis—Zoledronate—osteoporosis	0.000398	0.000873	CcSEcCtD
Oxymorphone—Headache—Zoledronate—osteoporosis	0.000396	0.000868	CcSEcCtD
Oxymorphone—Vomiting—Conjugated Estrogens—osteoporosis	0.000387	0.000848	CcSEcCtD
Oxymorphone—Urticaria—Estradiol—osteoporosis	0.000387	0.000848	CcSEcCtD
Oxymorphone—Abdominal pain—Estradiol—osteoporosis	0.000385	0.000844	CcSEcCtD
Oxymorphone—Body temperature increased—Estradiol—osteoporosis	0.000385	0.000844	CcSEcCtD
Oxymorphone—Dermatitis—Conjugated Estrogens—osteoporosis	0.000384	0.00084	CcSEcCtD
Oxymorphone—Headache—Conjugated Estrogens—osteoporosis	0.000381	0.000836	CcSEcCtD
Oxymorphone—Nausea—Zoledronate—osteoporosis	0.000376	0.000823	CcSEcCtD
Oxymorphone—Nausea—Conjugated Estrogens—osteoporosis	0.000362	0.000793	CcSEcCtD
Oxymorphone—Hypersensitivity—Estradiol—osteoporosis	0.000359	0.000787	CcSEcCtD
Oxymorphone—Asthenia—Estradiol—osteoporosis	0.00035	0.000766	CcSEcCtD
Oxymorphone—Pruritus—Estradiol—osteoporosis	0.000345	0.000755	CcSEcCtD
Oxymorphone—Diarrhoea—Estradiol—osteoporosis	0.000333	0.000731	CcSEcCtD
Oxymorphone—Dizziness—Estradiol—osteoporosis	0.000322	0.000706	CcSEcCtD
Oxymorphone—Vomiting—Estradiol—osteoporosis	0.00031	0.000679	CcSEcCtD
Oxymorphone—Dermatitis—Estradiol—osteoporosis	0.000307	0.000673	CcSEcCtD
Oxymorphone—Headache—Estradiol—osteoporosis	0.000305	0.000669	CcSEcCtD
Oxymorphone—Nausea—Estradiol—osteoporosis	0.000289	0.000634	CcSEcCtD
Oxymorphone—Naloxone—ESR1—osteoporosis	0.000157	1	CrCbGaD
Oxymorphone—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	2e-05	0.00548	CbGpPWpGaD
Oxymorphone—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.98e-05	0.00542	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—PTHLH—osteoporosis	1.98e-05	0.0054	CbGpPWpGaD
Oxymorphone—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	1.98e-05	0.0054	CbGpPWpGaD
Oxymorphone—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	1.98e-05	0.0054	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—WNT1—osteoporosis	1.92e-05	0.00524	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PTH1R—osteoporosis	1.9e-05	0.0052	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CALCR—osteoporosis	1.9e-05	0.0052	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—MGLL—osteoporosis	1.85e-05	0.00506	CbGpPWpGaD
Oxymorphone—OPRK1—G alpha (i) signalling events—ADCY5—osteoporosis	1.79e-05	0.0049	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—MGLL—osteoporosis	1.79e-05	0.00489	CbGpPWpGaD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—POMC—osteoporosis	1.78e-05	0.00487	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—IL1B—osteoporosis	1.78e-05	0.00487	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—PTH—osteoporosis	1.77e-05	0.00483	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—CALCA—osteoporosis	1.74e-05	0.00476	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—PTHLH—osteoporosis	1.73e-05	0.00474	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CALCR—osteoporosis	1.73e-05	0.00472	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PTH1R—osteoporosis	1.73e-05	0.00472	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CNR2—osteoporosis	1.72e-05	0.00471	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—MGLL—osteoporosis	1.62e-05	0.00444	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—WNT1—osteoporosis	1.62e-05	0.00443	CbGpPWpGaD
Oxymorphone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	1.6e-05	0.00437	CbGpPWpGaD
Oxymorphone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	1.58e-05	0.00431	CbGpPWpGaD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—POMC—osteoporosis	1.56e-05	0.00427	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—CALCA—osteoporosis	1.53e-05	0.00417	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SOST—osteoporosis	1.52e-05	0.00416	CbGpPWpGaD
Oxymorphone—OPRM1—G alpha (i) signalling events—ADCY5—osteoporosis	1.52e-05	0.00414	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—MGLL—osteoporosis	1.51e-05	0.00413	CbGpPWpGaD
Oxymorphone—OPRD1—G alpha (i) signalling events—POMC—osteoporosis	1.5e-05	0.00411	CbGpPWpGaD
Oxymorphone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.47e-05	0.00402	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—PTHLH—osteoporosis	1.47e-05	0.00401	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—TGFB1—osteoporosis	1.39e-05	0.00379	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CALCR—osteoporosis	1.38e-05	0.00376	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PTH1R—osteoporosis	1.38e-05	0.00376	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—MGLL—osteoporosis	1.37e-05	0.00375	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—PTH—osteoporosis	1.35e-05	0.00369	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SOST—osteoporosis	1.34e-05	0.00365	CbGpPWpGaD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—POMC—osteoporosis	1.32e-05	0.00361	CbGpPWpGaD
Oxymorphone—OPRK1—G alpha (i) signalling events—POMC—osteoporosis	1.32e-05	0.00361	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CNR2—osteoporosis	1.31e-05	0.00359	CbGpPWpGaD
Oxymorphone—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	1.31e-05	0.00358	CbGpPWpGaD
Oxymorphone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.3e-05	0.00354	CbGpPWpGaD
Oxymorphone—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	1.29e-05	0.00353	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CALCA—osteoporosis	1.29e-05	0.00353	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PTH—osteoporosis	1.22e-05	0.00335	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PTH1R—osteoporosis	1.21e-05	0.0033	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CALCR—osteoporosis	1.21e-05	0.0033	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.2e-05	0.00327	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CNR2—osteoporosis	1.19e-05	0.00326	CbGpPWpGaD
Oxymorphone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.19e-05	0.00325	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PTH—osteoporosis	1.18e-05	0.00323	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CNR2—osteoporosis	1.15e-05	0.00315	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SOST—osteoporosis	1.13e-05	0.00308	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—WNT1—osteoporosis	1.12e-05	0.00307	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—PTHLH—osteoporosis	1.12e-05	0.00305	CbGpPWpGaD
Oxymorphone—OPRM1—G alpha (i) signalling events—POMC—osteoporosis	1.11e-05	0.00305	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MGLL—osteoporosis	1.09e-05	0.00299	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PTH—osteoporosis	1.07e-05	0.00294	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—LRP5—osteoporosis	1.07e-05	0.00292	CbGpPWpGaD
Oxymorphone—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	1.05e-05	0.00288	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.05e-05	0.00287	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CNR2—osteoporosis	1.05e-05	0.00286	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—IL6—osteoporosis	1.04e-05	0.00285	CbGpPWpGaD
Oxymorphone—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	1.04e-05	0.00284	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—LRP6—osteoporosis	1.02e-05	0.00279	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CALCR—osteoporosis	1.02e-05	0.00279	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PTH1R—osteoporosis	1.02e-05	0.00279	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PTHLH—osteoporosis	1.01e-05	0.00277	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PTH—osteoporosis	1e-05	0.00273	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—WNT1—osteoporosis	9.84e-06	0.00269	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CALCA—osteoporosis	9.84e-06	0.00269	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PTHLH—osteoporosis	9.8e-06	0.00268	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CNR2—osteoporosis	9.74e-06	0.00266	CbGpPWpGaD
Oxymorphone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	9.61e-06	0.00263	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MGLL—osteoporosis	9.59e-06	0.00262	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—LRP5—osteoporosis	9.36e-06	0.00256	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—POMC—osteoporosis	9.11e-06	0.00249	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PTH—osteoporosis	9.08e-06	0.00248	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—LRP6—osteoporosis	8.96e-06	0.00245	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CALCA—osteoporosis	8.94e-06	0.00244	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PTHLH—osteoporosis	8.9e-06	0.00243	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	8.87e-06	0.00242	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CNR2—osteoporosis	8.85e-06	0.00242	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CALCA—osteoporosis	8.63e-06	0.00236	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TLN1—osteoporosis	8.63e-06	0.00236	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—WNT1—osteoporosis	8.32e-06	0.00227	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PTHLH—osteoporosis	8.28e-06	0.00226	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MGLL—osteoporosis	8.11e-06	0.00222	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—POMC—osteoporosis	7.99e-06	0.00218	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—LRP5—osteoporosis	7.91e-06	0.00216	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CALCA—osteoporosis	7.83e-06	0.00214	CbGpPWpGaD
Oxymorphone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	7.79e-06	0.00213	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—LRP6—osteoporosis	7.57e-06	0.00207	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TLN1—osteoporosis	7.56e-06	0.00207	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PTHLH—osteoporosis	7.52e-06	0.00206	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—P4HB—osteoporosis	7.44e-06	0.00203	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CALCA—osteoporosis	7.29e-06	0.00199	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PTH—osteoporosis	7.24e-06	0.00198	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—RAP1A—osteoporosis	7.11e-06	0.00194	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CNR2—osteoporosis	7.05e-06	0.00193	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—ADCY5—osteoporosis	7e-06	0.00191	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NFATC1—osteoporosis	6.94e-06	0.0019	CbGpPWpGaD
Oxymorphone—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	6.88e-06	0.00188	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—DKK1—osteoporosis	6.88e-06	0.00188	CbGpPWpGaD
Oxymorphone—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	6.79e-06	0.00186	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—POMC—osteoporosis	6.75e-06	0.00184	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—WNT1—osteoporosis	6.63e-06	0.00181	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CALCA—osteoporosis	6.62e-06	0.00181	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—P4HB—osteoporosis	6.52e-06	0.00178	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—FGA—osteoporosis	6.45e-06	0.00176	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TLN1—osteoporosis	6.39e-06	0.00175	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—ADCY5—osteoporosis	6.36e-06	0.00174	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PTH—osteoporosis	6.34e-06	0.00173	CbGpPWpGaD
Oxymorphone—CYP2D6—Biological oxidations—POMC—osteoporosis	6.33e-06	0.00173	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—RAP1A—osteoporosis	6.24e-06	0.0017	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CNR2—osteoporosis	6.18e-06	0.00169	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—ADCY5—osteoporosis	6.14e-06	0.00168	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NFATC1—osteoporosis	6.08e-06	0.00166	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—DKK1—osteoporosis	6.03e-06	0.00165	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—BMP2—osteoporosis	6e-06	0.00164	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PTHLH—osteoporosis	6e-06	0.00164	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PKM—osteoporosis	5.97e-06	0.00163	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—FDPS—osteoporosis	5.97e-06	0.00163	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—FGB—osteoporosis	5.87e-06	0.0016	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—WNT1—osteoporosis	5.81e-06	0.00159	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PSMA2—osteoporosis	5.66e-06	0.00155	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PSMA5—osteoporosis	5.66e-06	0.00155	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GPD2—osteoporosis	5.66e-06	0.00155	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PGLS—osteoporosis	5.66e-06	0.00155	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—FGA—osteoporosis	5.65e-06	0.00155	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—ADCY5—osteoporosis	5.57e-06	0.00152	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—P4HB—osteoporosis	5.51e-06	0.00151	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PTH—osteoporosis	5.36e-06	0.00147	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CALCA—osteoporosis	5.28e-06	0.00144	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—RAP1A—osteoporosis	5.27e-06	0.00144	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PTHLH—osteoporosis	5.26e-06	0.00144	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—BMP2—osteoporosis	5.26e-06	0.00144	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CNR2—osteoporosis	5.23e-06	0.00143	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—ADCY5—osteoporosis	5.19e-06	0.00142	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ATIC—osteoporosis	5.17e-06	0.00141	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PNP—osteoporosis	5.17e-06	0.00141	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—POMC—osteoporosis	5.15e-06	0.00141	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—FGB—osteoporosis	5.14e-06	0.00141	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NFATC1—osteoporosis	5.14e-06	0.0014	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—DKK1—osteoporosis	5.1e-06	0.00139	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PSMA2—osteoporosis	4.97e-06	0.00136	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PSMA5—osteoporosis	4.97e-06	0.00136	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—WNT1—osteoporosis	4.91e-06	0.00134	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—KL—osteoporosis	4.79e-06	0.00131	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—FGA—osteoporosis	4.78e-06	0.00131	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—ADCY5—osteoporosis	4.71e-06	0.00129	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—POMC—osteoporosis	4.67e-06	0.00128	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CALCA—osteoporosis	4.63e-06	0.00126	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL6R—osteoporosis	4.56e-06	0.00125	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—POMC—osteoporosis	4.51e-06	0.00123	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—BMP2—osteoporosis	4.44e-06	0.00121	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PTHLH—osteoporosis	4.44e-06	0.00121	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—OXCT1—osteoporosis	4.4e-06	0.0012	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CA2—osteoporosis	4.4e-06	0.0012	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—FGB—osteoporosis	4.35e-06	0.00119	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—MGLL—osteoporosis	4.29e-06	0.00117	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—KL—osteoporosis	4.2e-06	0.00115	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PSMA2—osteoporosis	4.2e-06	0.00115	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PSMA5—osteoporosis	4.2e-06	0.00115	CbGpPWpGaD
Oxymorphone—CYP3A4—Biological oxidations—POMC—osteoporosis	4.14e-06	0.00113	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—POMC—osteoporosis	4.1e-06	0.00112	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL6R—osteoporosis	4e-06	0.00109	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CALCA—osteoporosis	3.91e-06	0.00107	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—FDPS—osteoporosis	3.9e-06	0.00107	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PKM—osteoporosis	3.9e-06	0.00107	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—POMC—osteoporosis	3.82e-06	0.00104	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—ADCY5—osteoporosis	3.75e-06	0.00103	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PGLS—osteoporosis	3.7e-06	0.00101	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GPD2—osteoporosis	3.7e-06	0.00101	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—IDH2—osteoporosis	3.65e-06	0.000996	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SPP1—osteoporosis	3.63e-06	0.000993	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KL—osteoporosis	3.55e-06	0.000971	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—POMC—osteoporosis	3.46e-06	0.000947	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP27A1—osteoporosis	3.43e-06	0.000937	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PNP—osteoporosis	3.38e-06	0.000924	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ATIC—osteoporosis	3.38e-06	0.000924	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL6R—osteoporosis	3.38e-06	0.000924	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ACP5—osteoporosis	3.33e-06	0.000911	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ADCY5—osteoporosis	3.29e-06	0.0009	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IRS2—osteoporosis	3.28e-06	0.000898	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—LEP—osteoporosis	3.21e-06	0.000879	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SPP1—osteoporosis	3.19e-06	0.00087	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—TPI1—osteoporosis	3.1e-06	0.000847	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—ESR1—osteoporosis	3.07e-06	0.000839	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—P4HB—osteoporosis	2.91e-06	0.000796	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IRS2—osteoporosis	2.88e-06	0.000787	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—OXCT1—osteoporosis	2.88e-06	0.000786	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CA2—osteoporosis	2.88e-06	0.000786	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IRS1—osteoporosis	2.87e-06	0.000784	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GAPDH—osteoporosis	2.86e-06	0.000782	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—LEP—osteoporosis	2.82e-06	0.00077	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—MGLL—osteoporosis	2.8e-06	0.000766	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—RAP1A—osteoporosis	2.79e-06	0.000761	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ADCY5—osteoporosis	2.78e-06	0.00076	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—POMC—osteoporosis	2.76e-06	0.000755	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL6R—osteoporosis	2.69e-06	0.000736	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SPP1—osteoporosis	2.69e-06	0.000736	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ESR1—osteoporosis	2.69e-06	0.000735	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IGF1—osteoporosis	2.66e-06	0.000726	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IRS1—osteoporosis	2.51e-06	0.000687	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IRS2—osteoporosis	2.43e-06	0.000665	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—POMC—osteoporosis	2.42e-06	0.000662	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—IDH2—osteoporosis	2.38e-06	0.000651	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—LEP—osteoporosis	2.38e-06	0.000651	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL6R—osteoporosis	2.36e-06	0.000646	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IGF1—osteoporosis	2.33e-06	0.000637	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ESR1—osteoporosis	2.27e-06	0.000622	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ENO1—osteoporosis	2.25e-06	0.000615	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.24e-06	0.000612	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PSMA2—osteoporosis	2.22e-06	0.000606	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PSMA5—osteoporosis	2.22e-06	0.000606	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ACP5—osteoporosis	2.18e-06	0.000596	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IRS1—osteoporosis	2.13e-06	0.000581	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—POMC—osteoporosis	2.05e-06	0.000559	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL6—osteoporosis	2.03e-06	0.000555	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—TPI1—osteoporosis	2.03e-06	0.000554	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL6R—osteoporosis	2e-06	0.000546	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IGF1—osteoporosis	1.97e-06	0.000538	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—P4HB—osteoporosis	1.91e-06	0.000521	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GAPDH—osteoporosis	1.87e-06	0.000511	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—RAP1A—osteoporosis	1.82e-06	0.000498	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.8e-06	0.000492	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL6—osteoporosis	1.78e-06	0.000487	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MYC—osteoporosis	1.6e-06	0.000436	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TGFB1—osteoporosis	1.59e-06	0.000435	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL6—osteoporosis	1.51e-06	0.000411	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ENO1—osteoporosis	1.47e-06	0.000402	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ADCY5—osteoporosis	1.47e-06	0.000402	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GPX1—osteoporosis	1.47e-06	0.000401	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PSMA5—osteoporosis	1.45e-06	0.000396	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PSMA2—osteoporosis	1.45e-06	0.000396	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MYC—osteoporosis	1.4e-06	0.000383	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TGFB1—osteoporosis	1.4e-06	0.000382	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—MTHFR—osteoporosis	1.35e-06	0.00037	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL6—osteoporosis	1.2e-06	0.000328	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MYC—osteoporosis	1.18e-06	0.000323	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TGFB1—osteoporosis	1.18e-06	0.000323	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.18e-06	0.000322	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—POMC—osteoporosis	1.08e-06	0.000296	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL6—osteoporosis	1.05e-06	0.000288	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ADCY5—osteoporosis	9.62e-07	0.000263	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GPX1—osteoporosis	9.58e-07	0.000262	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL6—osteoporosis	8.89e-07	0.000243	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—MTHFR—osteoporosis	8.85e-07	0.000242	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—POMC—osteoporosis	7.07e-07	0.000193	CbGpPWpGaD
